Aurinia Pharmaceuticals Inc (AUPH)
SG&A Expense Growth
6.71%
Quarterly · Period ending:
AUPH SG&A Expense Growth
Latest reported6.71%period ending
Latest reported6.71%period ending
AUPH Quarterly SG&A Growth (QoQ) (0.00% → 6.71%)
Latest values, visible window
High-resolution chart · PNG
AUPH sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 6.7139% | |
| -24.7001% | |
| 11.7371% | |
| 0.6303% | |
| 27.9217% | |
| -55.0589% | |
| 6.8213% | |
| -5.7128% | |
| -5.7889% | |
| -4.7472% | |
| 4.8431% | |
| 9.4361% | |
| -12.9339% | |
| 5.5842% | |
| -9.0015% | |
| 1.2361% | |
| 14.0164% | |
| 2.1586% | |
| -0.9027% | |
| 0.7288% | |
| 11.3478% | |
| -0.6564% | |
| 30.5062% | |
| 98.7313% | |
| 39.772% | |
| 52.5393% | |
| 19.5512% | |
| 22.5435% | |
| 26.788% | |
| 11.5209% | |
| 19.6716% | |
| -15.569% | |
| -8.6784% | |
| 21.5843% | |
| 17.6604% | |
| -8.6522% | |
| -15.3487% | |
| 53.8841% | |
| 29.7786% | |
| -6.485% | |
| 53.943% | |
| -23.7852% | |
| 13.3333% | |
| -2.4045% | |
| -25.7743% | |
| 36.1687% | |
| -0.427% | |
| -17.9802% | |
| -27.8129% | |
| 181.3929% | |
| 70.2422% | |
| 3.6171% | |
| -2.3279% | |
| -45.8535% | |
| -8.6534% | |
| 1.5649% | |
| -1.409% | |
| 28.0571% | |
| 17.4239% | |
| -2.9676% | |
| -7.1514% | |
| -36.3952% | |
| 51.9106% | |
| 16.3504% | |
| -8.7609% | |
| -2.9978% | |
| 16.1033% | |
| -45.9344% | |
| 41.2687% | |
| 51.4228% | |
| -50.1709% | |
| -29.5457% | |
| 7.8764% | |
| 22.8355% | |
| -13.3622% | |
| -1.0202% | |
| -17.6771% | |
| 10.2081% | |
| 3.5357% | |
| -14.2365% | |
| 5.692% | |
| -49.3407% | |
| 70.6396% | |
| 9.6783% | |
| -40.5338% | |
| 37.4778% | |
| 38.7561% | |
| -37.0635% | |
| 39.3866% | |
| -24.2582% | |
| 4.6664% | |
| -14.9575% | |
| 93.696% | |
| 9.5407% | |
| 17.7003% | |
| -45.3876% | |
| 85.5161% | |
| 0% | |
| 7.5177% | |
| -9.147% |